INIS
management
100%
nose
100%
therapy
60%
interleukins
60%
asthma
60%
tissues
40%
inflammation
40%
biological markers
40%
levels
20%
drugs
20%
patients
20%
phenotype
20%
diseases
20%
reviews
20%
usa
20%
cytokines
20%
investigations
20%
europe
20%
pharmacotherapy
20%
eosinophils
20%
mucosa
20%
mast cells
20%
immunoglobulins
20%
basophils
20%
Medicine and Dentistry
Chronic Rhinosinusitis
100%
Nasal Polyp
55%
Combination Therapy
44%
Asthma
33%
Diseases
22%
Biological Marker
22%
Pathophysiology
22%
Tissues
22%
Therapeutic Procedure
22%
Development
11%
Phenotype
11%
Drug Therapy
11%
Immunoglobulin E
11%
Mast Cell
11%
Basophil Cell
11%
Serositis
11%
Cytokine
11%
Placebo-Controlled Study
11%
Interleukin 5
11%
Biological Therapy
11%
Interleukin 13
11%
Mucosa
11%
Interleukin 4
11%
Chemotherapeutic Agent
11%
Drug
11%
Patient
11%
Comprehension
11%
Eosinophil
11%
Amaurosis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Rhinosinusitis
100%
Nose Polyp
55%
Asthma
33%
Diseases
22%
Pathophysiology
22%
Biological Marker
22%
Inflammation
11%
Placebo-Controlled Study
11%
Cytokine
11%
Immunoglobulin E
11%
Interleukin 4
11%
Drug
11%
Interleukin 13
11%
Interleukin 5
11%
Blindness
11%
Pharmacotherapy
11%